
Actavis to acquire Allergan
Actavis is to acquire pharmaceutical company Allergan for a combination of USD129.22 in cash and 0.3683 Actavis shares for each share of Allergan common stock. Based on the closing price of Actavis shares on 14 November, 2014, the transaction




